User login

Hatch Says He May Oppose TPP Without 12-Year Data Exclusivity For Biologics

January 28, 2015 at 3:37 PM
Senate Finance Committee Chairman Orrin Hatch (R-UT) has said he may oppose a Trans-Pacific Partnership (TPP) agreement if it does not commit signatories to put in place 12 years of regulatory data exclusivity for an emerging class of advanced medicines called biologics. "I'm very, very strong on the 12-year matter. Look, we have a great biologic industry in this country. It could be even greater, but ... they can't afford the expenses and the time and all the other things...

Not a subscriber? You can request 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Biden era.